|Hospital:||IST Istituto Nazionale per la Ricerca sul Cancro|
|Patients: This study involved 11 patients with inoperable malignant pleural mesothelioma. None of the patients had been administered chemotherapy before.|
Treatment: The treatment consisted of two chemotherapy drugs, oxaliplatin (eloxatin) and raltitrexed
Toxicity: Grade 3 or 4 toxicities included gastrointestinal, diarrhea, asthenia, neurotoxicity, and transaminase elevation.
Results: Overall survival was not discussed, but the median time to progression (when the cancers grew) was 16.5 weeks.
Correspondence: Dr. Roberto Maisano